相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small cell lung cancer (NSCLC)
Carmen Trinidad Lopez et al.
EUROPEAN RADIOLOGY EXPERIMENTAL (2019)
Predictive value and clinical significance of increased SSAT-1 activity in healthy adults
Paramjit S. Tappia et al.
FUTURE SCIENCE OA (2019)
Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer
Andrew W. Maksymiuk et al.
FUTURE SCIENCE OA (2019)
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Sarah B. Goldberg et al.
CLINICAL CANCER RESEARCH (2018)
Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer
Sharyn I. Katz et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Immune checkpoint inhibitors and small cell lung cancer: what's new?
Sabine Schmid et al.
JOURNAL OF THORACIC DISEASE (2018)
Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials
Muhammad Khan et al.
MEDICINE (2018)
Spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker in human cancer
Andrew W. Maksymiuk et al.
FUTURE SCIENCE OA (2018)
Symptomatic pseudo-progression followed by significant treatment response in two lung cancer patients treated with immunotherapy
Maximilian J. Hochmair et al.
LUNG CANCER (2017)
Response Evaluation of Chemotherapy for Lung Cancer
Ki-Eun Hwang et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2017)
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy
Benjamin Y. Kong et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pseudoprogression and Immune-Related Response in Solid Tumors
Victoria L. Chiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Improved Endpoints for Cancer Immunotherapy Trials
Axel Hoos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
分享论文
